Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the audited financial results for the quarter and year ended 31 March 2022. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the transcript has been placed on the company's website. The document itself is short (1415 characters) and does not contain the transcript text but announces its availability. According to the 'Menu vs Meal' rule, such a document is an announcement of a report (the transcript) rather than the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and for announcements of reports.
2022-05-30 English
Loss of share certificate
Major Shareholding Notification Classification · 95% confidence The document consists primarily of tabular data listing shareholders, folio numbers, share certificates, and distinctive share numbers. There is no narrative text, financial data, or discussion of company performance, management, or governance. The document is very short (944 characters) and appears to be a list of shareholders or shareholding details. This type of document aligns best with a Major Shareholding Notification (MRQ), which involves notifications of changes or details in significant share ownership levels. There is no indication of voting results, management changes, or financial reporting. Therefore, the classification is MRQ with high confidence.
2022-05-27 English
Intimation of Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by certain shareholders. It includes details such as folio numbers, shareholder names, share counts, certificate numbers, and distinctive numbers. The letter requests the exchanges to inform trading members to refrain from trading these shares and mentions the issuance of duplicate certificates upon receipt of required documents. The document also encloses a letter from the Registrar and Transfer Agent (RTA) confirming receipt of the information. This type of filing is a regulatory announcement related to share certificate loss and does not contain financial statements, management discussion, or other report content. It is a compliance disclosure under SEBI regulations, fitting best under Regulatory Filings (RNS). The document length is 4322 characters, which is relatively short and is an announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2022-05-27 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Torrent Pharmaceuticals has acquired four brands from Dr. Reddy's Laboratories. It is addressed to stock exchanges and includes details about the acquisition and company background. The document is short (3024 characters) and primarily serves as an announcement of a corporate transaction rather than a detailed financial report or regulatory filing. It does not contain financial statements, management discussion, or detailed merger documentation. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through acquisition.
2022-05-26 English
Torrent Pharma acquires 4 Brands from Dr. Reddy's laboratories
Capital/Financing Update Classification · 95% confidence The document is a press release announcing Torrent Pharmaceuticals' acquisition of four brands from Dr. Reddy's Laboratories. It is addressed to stock exchanges and includes details about the acquisition and company background. The document is short (3024 characters) and serves as an announcement of a corporate transaction related to acquisition of brands, which fits the category of Capital/Financing Update (CAP). It is not a full financial report, audit, or regulatory filing, nor is it a voting result or management change announcement. Therefore, the best classification is CAP with high confidence.
2022-05-26 English
In continuation of our letter dated 20-May-22 and pm''suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem??nts) Regulations, 2015, the audio recording of ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of a conference call with analysts and investors about the audited financial results for the quarter and year ended 31st March 2022. It references a previous letter and provides a link to the audio recording. The document is short (1458 characters) and serves as an announcement of the availability of the conference call recording rather than the transcript itself. Therefore, it is not a full Call Transcript (CT) but rather a Regulatory Filing (RNS) announcing the availability of the recording, consistent with the MENU VS MEAL RULE and the nature of the content.
2022-05-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.